To validate screen hits corresponding to CAF1 roles in the maintenance of BL EBV latency, control or independent CHAF1B-targeting sgRNAs were expressed in P3HR-1, Akata, and MUTU I Cas9+ tumor-derived endemic Burkitt lymphoma cell lines. The gene discussed is CHAF1A; the disease is neoplasm.